You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. A Rapid Method for HLA-typing by Haplotyping

    SBC: GENERATION BIOTECH, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Identification of Human Leukocyte Antigens, HLA, for matching of kidney and bone marrow donors and recipients is mandatory for transplantation. Many allele combinations fail to be resolved with current typing methods.

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  2. IMAGING NETWORK FOR BREAST CANCER MASS SCREENING

    SBC: ARTANN LABORATORIES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Early detection of breast cancer remains one of the most significant challenges in health care. The tactile breast imager (TBI) is a promising solution that electronically captures the sense of touch to provide a qu

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  3. A High-Throughput Cell-based Drug Discovery System

    SBC: GENOME DATA SYSTEMS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): This Phase II SBIR project is focused at the development of a high-throughput screening method and instrument for drug discovery using miniaturized, cell-based assays. For developing new drugs against complex dise

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  4. THERAPEUTIC USE OF INTER-ALPHA INHIBITOR IN SEPSIS

    SBC: PROTHERA BIOLOGICS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The goal of the proposed research is to demonstrate that Inter-alpha serine protease inhibitor proteins (IaIp) are an effective therapy for sepsis. In sepsis, normally high plasma levels of IaIp drop dramatically in

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  5. A Dual Molecular/Tumor Targeting Therapy for PanCa

    SBC: SYNERGENE THERAPEUTICS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Approximately 30,000 people in the United States are diagnosed each year with pancreatic cancer (PanCa). Over 90% of these will die of the disease making PanCa one of the most devastating human malignancies. The c

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  6. Developing antiviral agents that inhibit HCV translation

    SBC: PTC THERAPEUTICS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): It is estimated that over 170 million people are infected by hepatitis C virus (HCV) worldwide. Currently, there are limited therapeutic agents and no vaccine available for HCV infection. Thus, it is necessary to deve

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  7. A Self-Monitoring Artificial Vascular Graft

    SBC: DVX, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Most artificial vascular grafts, of which 60,000 were implanted in the USA last year, fail in less than three years, leading to amputation. Diminishing blood flow through the graft has been shown to be a precursor o

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  8. A BREATH TEST FOR LUNG CANCER

    SBC: MENSSANA RESEARCH INC            Topic: N/A

    DESCRIPTION (provided by applicant): Background: Primary carcinoma of the lung is the leading cause of cancer death in the United States. A test that detects early-stage disease could potentially reduce the number of deaths. A breath test for volatile organic compounds (VOCs) was sensitive and specific for primary lung cancer in two multicenter clinical studies. A third multicenter study confirmed ...

    SBIR Phase II 2007 Department of Health and Human ServicesNational Institutes of Health
  9. Development of Resource Kit for Adolescent Cessation

    SBC: Toborg Associates, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): Five hundred thirty-four counties in 18 states are home to 29,497,852 persons and grow tobacco. Data indicate youth in these areas use tobacco earlier and use it more frequently. Tobacco communities have a unique per

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  10. Computerized Adaptive Version of the PEDI

    SBC: QUALITYMETRIC, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Our objective is to achieve a major advance in the technology used to assess disability in children and youth. Measurement and practical requirements for identifying disability and evaluating individual progress ac

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government